1st Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
—
Expenses
$447,218
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget

LobbyistCovered position, as disclosed
JOHN COSTER New —
CHRISTOPHER DAVIS New —
MARK D HENDRICKSON New —
JASON R MONEY —

Contacted: Patent & Trademark Office (PTO); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Food & Drug Administration (FDA); Congressional Budget Office (CBO); White House Office; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Trade (domestic/foreign) TRD

Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

LobbyistCovered position, as disclosed
JOHN COSTER New —
CHRISTOPHER DAVIS New —
MARK D HENDRICKSON New —
JASON R MONEY —

Contacted: Commerce, Dept of (DOC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); White House Office; Patent & Trademark Office (PTO); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs H.R.5 - Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 S.23 and H.R.1249 - America Invents Act, Sections 10 and 11 (Supplemental Examination) S.27 - Preserve Access to Affordable Generics Act, all provisions S.373 - Fair Prescription Drug Competition Act

LobbyistCovered position, as disclosed
JOHN COSTER New —
CHRISTOPHER DAVIS New —
MARK D HENDRICKSON New —
JASON R MONEY —

Contacted: Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Congressional Budget Office (CBO); Patent & Trademark Office (PTO); SENATE; White House Office; Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 23 (112th), H.R. 5 (112th), H.R. 1249 (112th), S. 27 (112th), S. 373 (112th)

Medicare/Medicaid MMM

FY11 and FY12 Budget, Implementation of Health Care Reform, Medicaid Rebates, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, generic drugs S.44 - Medicare Prescription Drug Negotiation Act

LobbyistCovered position, as disclosed
JOHN COSTER New —
CHRISTOPHER DAVIS New —
MARK D HENDRICKSON New —
JASON R MONEY —

Contacted: Federal Trade Commission (FTC); Congressional Budget Office (CBO); Food & Drug Administration (FDA); Office of Management & Budget (OMB); White House Office; SENATE; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 44 (112th)

Pharmacy PHA

FY 2011 and FY2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, and generic drugs S.44 - Medicare Prescription Drug Negotiation Act S.296 - Preserving Access to Life-Saving Medications Act S.373 - Fair Prescripton Drug Competition Act

LobbyistCovered position, as disclosed
JOHN COSTER New —
CHRISTOPHER DAVIS New —
MARK D HENDRICKSON New —
JASON R MONEY —

Contacted: Federal Trade Commission (FTC); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); White House Office; Office of Management & Budget (OMB); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); SENATE

Bills named: S. 296 (112th), S. 44 (112th), S. 373 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.